MACIR
Macrophage immunometabolism regulator
Also known as: C5orf30, FLJ25291, MACIR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96GV9
- Gene
- MACIR
- Ensembl
- ENSG00000181751
- Chromosome
- 5
- Canonical length
- 206 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Actin filaments,Primary cilium,Cytosol
OverviewNCBI Gene
This gene, MACIR (previously known as C5orf30), has been associated with rheumatoid arthritis, functioning as a negative regulator of tissue damage and modulating the activity of synovial fibroblasts and macrophages. The encoded protein is highly conserved in vertebrate genomes but has no significant similarity to any other human protein. [provided by RefSeq, Dec 2019]
Canonical amino-acid sequenceUniProt
206 residues, UniProt reviewed canonical sequence.
>Q96GV9|MACIR
1 MEVDINGESR STLTTLPFPG AEANSPGKAE AEKPRCSSTP CSPMRRTVSG YQILHMDSNY
61 LVGFTTGEEL LKLAQKCTGG EESKAEAMPS LRSKQLDAGL ARSSRLYKTR SRYYQPYEIP
121 AVNGRRRRRM PSSGDKCTKS LPYEPYKALH GPLPLCLLKG KRAHSKSLDY LNLDKMIKEP
181 ADTEVLQYQL QHLTLRGDRV FARNNTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MACIR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 30 nTPM
- colon: 21 nTPM
- rectum: 20 nTPM
- cerebral cortex: 20 nTPM
- retina: 19 nTPM
- spinal cord: 18 nTPM
Single-cell type
- extravillous trophoblasts: 151 nCPM
- platelets: 122 nCPM
- neutrophils: 93 nCPM
- neutrophil progenitors: 91 nCPM
- colonocytes: 65 nCPM
- megakaryocyte-erythroid progenitors: 63 nCPM
Immune cell
- basophil: 38 nTPM
- NK-cell: 7.3 nTPM
- T-reg: 7.3 nTPM
- eosinophil: 6.2 nTPM
- memory B-cell: 4.2 nTPM
- classical monocyte: 3.7 nTPM
Brain region
- white matter: 45 nTPM
- cerebral cortex: 32 nTPM
- thalamus: 29 nTPM
- basal ganglia: 29 nTPM
- midbrain: 27 nTPM
- spinal cord: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0.43
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- epithelial cell migration
- fibroblast migration
- inflammatory response
- negative regulation of cytokine production involved in inflammatory response
- negative regulation of epithelial cell migration
- negative regulation of fibroblast migration
- negative regulation of inflammatory response
- protein transport
Cellular components
Protein domainsUniProt · Pfam · InterPro
- UNC119-binding protein
- UNC119-binding protein C5orf30 homologue
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MACIR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MACIR as an antibody target. Whether an autoantibody or antibody against MACIR could matter depends on whether native MACIR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MACIR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MACIR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...